Nisa Investment Advisors
FHTX icon

Nisa Investment Advisors’s Foghorn Therapeutics FHTX Stock Holding History

Nisa Investment Advisors’s Portfolio FHTX Stock Details FHTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$381 Sell
78
-5,160
-99% -$22.9K ﹤0.01% 2979
2026
Q1 		$25K Hold
5,238
– – ﹤0.01% 1927
2025
Q4 		$28.3K Hold
5,238
– – ﹤0.01% 1809
2025
Q3 		$25.6K Hold
5,238
– – ﹤0.01% 1885
2025
Q2 		$24.6K Buy
5,238
+181
+4% +$756 ﹤0.01% 1847
2025
Q1 		$18.5K Sell
5,057
-30
-0.6% -$137 ﹤0.01% 1914
2024
Q4 		$24K Hold
5,087
– – ﹤0.01% 1883
2024
Q3 		$47.4K Buy
5,087
+72
+1% +$521 ﹤0.01% 1657
2024
Q2 		$28.8K Buy
5,015
+11
+0.2% +$66 ﹤0.01% 1819
2024
Q1 		$33.6K Buy
5,004
+4
+0.1% +$22 ﹤0.01% 1750
2023
Q4 		$32.3K Buy
5,000
+4,437
+788% +$19.1K ﹤0.01% 1736
2023
Q3 		$2.81K Buy
563
+50
+10% +$385 ﹤0.01% 2325
2023
Q2 		$3.61K Hold
513
– – ﹤0.01% 2342
2023
Q1 		$3K Sell
513
-12
-2% -$79 ﹤0.01% 2282
2022
Q4 		$3K Buy
+525
New +$3.96K ﹤0.01% 2337

Other funds holding FHTX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
PAM
Panagora Asset Management Boston, Massachusetts $32.6B AUM 52.29% 1-Year Est. Return
SCM
SCS Capital Management Boston, Massachusetts $10.6B AUM 19.73% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
PAP
Persistent Asset Partners Hong Kong $335M AUM 275.57% 1-Year Est. Return
Deutsche Bank
Deutsche Bank Frankfurt Am Main Ge, Germany $344B AUM 42.99% 1-Year Est. Return
GCP
GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return
Citigroup
Citigroup New York $303B AUM 53.02% 1-Year Est. Return
DT
Diversified Trust Memphis, Tennessee $6.24B AUM 28.78% 1-Year Est. Return

Nisa Investment Advisors's FHTX Position: Q2 2026 in Review

Nisa Investment Advisors reduced its Foghorn Therapeutics (FHTX) stake by 99% in Q2 2026, selling an estimated $22.9K and leaving 78 shares worth $381. The position accounts for ﹤0.01% of the portfolio, ranked #2979.

Nisa Investment Advisors first reported a position in FHTX in Q4 2022 and has held it in 15 quarters since. The position peaked at $47.4K in Q3 2024. 37 funds tracked by Wall St. Rank hold FHTX as of Q2 2026.

  • Nisa Investment Advisors held 78 shares of Foghorn Therapeutics worth $381 as of Q2 2026.
  • Nisa Investment Advisors sold 5,160 Foghorn Therapeutics shares in Q2 2026, an estimated $22.9K.
  • Foghorn Therapeutics made up ﹤0.01% of Nisa Investment Advisors's portfolio in Q2 2026, its #2979 holding.
  • Nisa Investment Advisors first reported a position in Foghorn Therapeutics in Q4 2022 and has held it in 15 quarters since.
  • Nisa Investment Advisors's Foghorn Therapeutics position peaked at $47.4K in Q3 2024.
  • 37 funds tracked by Wall St. Rank held Foghorn Therapeutics as of Q2 2026.

Based on Nisa Investment Advisors's 13F filing for Q2 2026, filed 10 Aug 2026.